List of insiders holdings for ArriVent BioPharma Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| HILLHOUSE INVESTMENT MANAGEMENT LTD. HHLR ADVISORS LTD. 10% Owner | 2024-02-01 16:47:58 | 0 4,484,672 | 4,484,672 | Form 4 |
| ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC OrbiMed Advisors IV Ltd OrbiMed Asia GP IV L.P. Director 10% Owner | 2024-02-05 16:42:18 | 3,027,328 0 | 3,027,328 | Form 13D |
| HEALY JAMES Director | 2024-01-31 16:10:47 | 0 1,696,752 | 1,696,752 | Form 4 |
| GORDON CARL L Director 10% Owner | 2024-01-31 16:11:43 | 0 1,513,664 | 1,513,664 | Form 4 |
| Yao Zhengbin President and CEO | 2024-01-25 20:39:51 | 756,351 613,138 | 1,369,489 | Form 3 |
| LaChapelle Robin Chief Operating Officer | 2024-01-25 20:38:51 | 267,159 394,477 | 661,636 | Form 3 |
| Lutzker Stuart President of R&D | 2024-01-25 20:39:12 | 373,251 0 | 373,251 | Form 3 |
| Kung Winston Chief Financial Officer | 2024-01-25 20:38:27 | 197,238 0 | 197,238 | Form 3 |
| Kastenmayer James Paul General Counsel | 2024-01-25 20:38:09 | 106,004 0 | 106,004 | Form 3 |
| Peterson Kristine Director | 2024-04-23 16:06:26 | 28,587 0 | 28,587 | Form 4 |
| Jallal Bahija Director | 2024-01-29 16:15:57 | 17,884 0 | 17,884 | Form 4 |
| Nolet Chris Director | 2024-01-29 16:16:13 | 17,884 0 | 17,884 | Form 4 |